Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Taecker Benjamin S.Chief Eng and Opr Officer | Tax withholding | F | $2,803 715 sh | Apr 15, 2026 |
| 9 | Neglen NiclasChief Financial Officer | Grant or award | A | — 129 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 9 | Brown Christopher (John)President, TTEC Digital | Tax withholding | F | $617 221 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 9 | Carillo BrookeChief Financial Officer | Option exercise | M | — 19.3K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 8 | Spector DavidDirector, Chairman & CEO | Open-market sale · 10b5-1 plan | SELL | $889K 9,583 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 8 | Mater Tonya L.SVP & Chief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $112K 2,000 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 8 | Markovich John M.Chief Financial Officer | Tax withholding | F | $123K 8,607 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 7 | Slessor MikeDirector, CEO | Open-market sale · 10b5-1 plan | SELL | $698K 5,432 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 7 | Siebel Thomas MDirector, Executive Chairman, 10% Owner | Option exercise · 10b5-1 plan | M | — 326.2K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 7 | Slessor MikeDirector, CEO | Open-market sale · 10b5-1 plan | SELL | $302K 2,369 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 7 | Brooks Jayme L.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $487K 5,703 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 5 | Nguyen DianeEVP, Chief Legal Officer & GC | Tax withholding | F | $58K 4,066 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 5 | Fordyce MarshallDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $41K 900 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 4 | Slessor MikeDirector, CEO | Open-market sale · 10b5-1 plan | SELL | $99K 767 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 4 | Slessor MikeDirector, CEO | Open-market sale · 10b5-1 plan | SELL | $114K 900 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 4 | Mater Tonya L.SVP & Chief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $147K 2,600 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 4 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 6,349 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 4 | Hoffmann MartinCEO | Open-market sale · 10b5-1 plan | SELL | $141K 4,150 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 4 | Mat IshbiaDirector, President and CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 11.00M sh | Apr 15, 2026 traded Apr 15, 2026 |
| 4 | Slessor MikeDirector, CEO | Open-market sale · 10b5-1 plan | SELL | $229K 1,826 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 4 | Craig Jonathan M.MD, Head of Retail Investing | Option exercise · 10b5-1 plan | M | $1.02M 21.8K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 4 | Yuan Eric S.Director, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 69.9K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 3 | Craig Jonathan M.MD, Head of Retail Investing | Option exercise · 10b5-1 plan | M | — 21.8K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 2 | Prober Charles J.Director | Option exercise · 10b5-1 plan | M | $89K 7,930 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 1 | Susi Roger E.Director, CEO, President, Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $197K 2,107 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 1 | Susi Roger E.Director, CEO, President, Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $238K 2,564 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 1 | Susi Roger E.Director, CEO, President, Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $170K 1,847 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 1 | Susi Roger E.Director, CEO, President, Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $55K 589 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Rote William E.Chief Research Officer | Grant or award · 10b5-1 plan | A | — 14.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 6,250 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 100.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Spector DavidDirector, Chairman & CEO | Open-market sale · 10b5-1 plan | SELL | $39K 417 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 0 | Susi Roger E.Director, CEO, President, Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $37K 393 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 3,542 sh | Apr 15, 2026 traded Apr 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $36K 3,542 sh | Apr 15, 2026 traded Apr 13, 2026 |